Trial Profile
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth. A Clinical, Multi-center, Prospective, Non-Randomized Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2022
Price :
$35
*
At a glance
- Drugs Anti-CD34 monoclonal antibody (Primary) ; Atorvastatin
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 07 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Jul 2010 New trial record